Back

Learner’s Digest International (TM)

  • Alzheimer Disease
  • Anticoagulants
  • Obesity
  • Sleep Apnea, Obstructive
  • Tirzepatide

Primary Care News: The Year’s Literature in 60 Minutes

The goal of this program is to improve management of common issues in primary care using recent data on medical advances. After hearing and assimilating this program, the clinician will be better able to: 1. Appraise recent clinical trials investigating amyloid removal to prevent progression of Alzheimer disease. 2. Select appropriate medications for reducing cirrhosis risk in patients with metabolic dysfunction-associated steatohepatitis. 3. Recognize the role of tirzepatide in managing patients with obstructive sleep apnea and obesity. 4. Utilize recently validated tools for cardiovascular risk stratification. 5. Optimize anticoagulation therapy for patients with stable coronary disease and atrial fibrillation.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

ABIM — Medical KnowledgeUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider · audio-digest.org

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Apr 15, 2029 3 years left